Kasia Owczarczyk

Honorary Senior Clinical Lecturer

King's College London

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom Professors in Medical Imaging Medical Imaging professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Kasia Owczarczyk is an Honorary Senior Clinical Lecturer at King's College London, UK. Her research focuses on advanced imaging techniques for cancer assessment, neoadjuvant therapy response, and survival outcomes in esophageal and gastric cancers. Recent publications include contributions to studies on the integration of diffusion-weighted imaging with T2-weighted MRI, as well as the impact of various treatment regimens on patient survival.

Articles (10)

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Collaborators (9)

Davide Prezzi

Honorary Senior Lecturer / Adjunct Senior Lecturer

King’s College London

UNITED KINGDOM

View details

Sugama Chicklore

King’s College London

UNITED KINGDOM

View details

Nisha Shaunak

Associate Chief Pharmacist, Cancer & Surgery

Guy's and St Thomas' NHS Foundation Trust

UNITED KINGDOM

View details

Vicky Goh

King’s College London

UNITED KINGDOM

View details

Richard Turkington

The Queen's University Belfast

UNITED KINGDOM

View details

Manil Subesinghe

King’s College London

UNITED KINGDOM

View details

Beth Russell

King’s College London

UNITED KINGDOM

View details

Gary Cook

King’s College London

UNITED KINGDOM

View details

Mieke Van Hemelrijck

King’s College London

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Kasia Owczarczyk

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Pelvic stereotactic ablative body radiotherapy (SABR) reirradiation: UK SABR consortium guidance for use in routine clinical care

Multicentre validation of CT grey-level co-occurrence matrix features for overall survival in primary oesophageal adenocarcinoma

Diffusion-weighted imaging complements T2-weighted MRI for tumour response assessment in squamous anal carcinoma.

Association of dynamic contrast-enhanced MRI and 18F-Fluorodeoxyglucose PET/CT parameters with neoadjuvant therapy response and survival in esophagogastric cancer

Metabolic tumour and nodal response to neoadjuvant chemotherapy on FDG PET-CT as a predictor of pathological response and survival in patients with oesophageal adenocarcinoma

Pathologic Lymph Node Regression After Neoadjuvant Chemotherapy Predicts Recurrence and Survival in Esophageal Adenocarcinoma

Correction: Diffusion-weighted imaging complements T2-weighted MRI for tumour response assessment in squamous anal carcinoma

The Impact of COVID-19 on the Delivery of Systemic Anti-Cancer Treatment at Guy’s Cancer Centre

Clinical Relevance of the Tumor Location-Modified Laurén Classification System for Gastric Cancer in a Western Population

Effect of peri-operative chemotherapy regimen on survival in the treatment of locally advanced oesophago-gastric adenocarcinoma – A comparison of the FLOT and ‘MAGIC’ regimens

Collaborators (9)

Davide Prezzi

Sugama Chicklore

Nisha Shaunak

Vicky Goh

Richard Turkington

Manil Subesinghe

Beth Russell

Gary Cook

Mieke Van Hemelrijck

Make your next move.

Kasia Owczarczyk

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Pelvic stereotactic ablative body radiotherapy (SABR) reirradiation: UK SABR consortium guidance for use in routine clinical care

Multicentre validation of CT grey-level co-occurrence matrix features for overall survival in primary oesophageal adenocarcinoma

Diffusion-weighted imaging complements T2-weighted MRI for tumour response assessment in squamous anal carcinoma.

Association of dynamic contrast-enhanced MRI and 18F-Fluorodeoxyglucose PET/CT parameters with neoadjuvant therapy response and survival in esophagogastric cancer

Metabolic tumour and nodal response to neoadjuvant chemotherapy on FDG PET-CT as a predictor of pathological response and survival in patients with oesophageal adenocarcinoma

Pathologic Lymph Node Regression After Neoadjuvant Chemotherapy Predicts Recurrence and Survival in Esophageal Adenocarcinoma

Correction: Diffusion-weighted imaging complements T2-weighted MRI for tumour response assessment in squamous anal carcinoma

The Impact of COVID-19 on the Delivery of Systemic Anti-Cancer Treatment at Guy&rsquo;s Cancer Centre

Clinical Relevance of the Tumor Location-Modified Laurén Classification System for Gastric Cancer in a Western Population

Effect of peri-operative chemotherapy regimen on survival in the treatment of locally advanced oesophago-gastric adenocarcinoma – A comparison of the FLOT and ‘MAGIC’ regimens

Collaborators (9)

Davide Prezzi

Sugama Chicklore

Nisha Shaunak

Vicky Goh

Richard Turkington

Manil Subesinghe

Beth Russell

Gary Cook

Mieke Van Hemelrijck

Make your next move.

The Impact of COVID-19 on the Delivery of Systemic Anti-Cancer Treatment at Guy’s Cancer Centre